Aprea Therapeutics Inc expected to post a loss of 36  cents a share - Earnings Preview

Aprea Therapeutics

02/05/2022 18:01

* Aprea Therapeutics Inc  APRE.OQ   APRE.O  is expected
to show no
change in quarterly revenue when it reports  results on May 4
(estimated). 
    * ​Refinitiv's mean analyst estimate for Aprea Therapeutics
Inc is
for a loss of 36 cents per share. For the same quarter last
year, the company reported a loss of 46 cents per share.
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Aprea
Therapeutics Inc is $3​, above​ its last closing price of $1.46.
​​​

This summary was machine generated May 2 at 17:00 GMT.  All
figures in US dollars  unless otherwise stated